Allergan outlines five different strategic options

During a first-quarter earnings conference call with investors, Allergan's chief executive, Brent Saunders, said that the company is “deep into the process” of its strategic review, which he outlined in a series of options. Allergan reported a revenue increase of 2.8 percent to $3.67 billion in the first quarter of ...

To continue reading this article subscribe now

barrier_image_OIC

Become a member today for full access from just €6,70 a week!

Buying a membership today will give you:

  • Our executive edition of Eyewear Intelligence (Regular PDF format or E-Format) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Unlimited access to ewintelligence.com - all insight, analysis and statistics available online
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Breaking news

Already an Eyewear Intelligence subscriber? Sign in here.